0001209191-15-058217.txt : 20150701
0001209191-15-058217.hdr.sgml : 20150701
20150701183700
ACCESSION NUMBER: 0001209191-15-058217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150701
DATE AS OF CHANGE: 20150701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORTHOFIX INTERNATIONAL N V
CENTRAL INDEX KEY: 0000884624
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 ABRAHAM DE VEERSTRAAT
STREET 2: CURACAO
CITY: NETHERLANDS ANTILLES
STATE: P8
ZIP: 00000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finegan Michael
CENTRAL INDEX KEY: 0001391402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19961
FILM NUMBER: 15966583
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-30
0
0000884624
ORTHOFIX INTERNATIONAL N V
OFIX
0001391402
Finegan Michael
3451 PLANO PARKWAY
LEWISVILLE
TX
75056
0
1
0
0
Chief Strategy Officer
Common Stock
2015-06-30
4
A
0
4050
0.00
A
64292
D
Common Stock
2015-06-30
4
A
0
8100
0.00
A
72392
D
Stock Option (right to buy)
33.12
2015-06-30
4
A
0
12150
0.00
A
2025-06-30
Common Stock
12150
12150
D
Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2015.
Represents performance-based vesting restricted stock. Under the terms of the grant, 50% of the restricted stock will vest if the Company achieves Adjusted EBITDA of $78.5 million or greater in any of the 2016, 2017 or 2018 fiscal years, and (ii) 50% will vest if the Company achieves ROIC of 12.2% or greater in any of the 2016, 2017 or 2018 fiscal years. In the event that the Adjusted EBITDA criteria and/or ROIC criteria is not achieved, pro rata vesting of 50-100% of that portion of the award will occur if 2018 fiscal year Adjusted EBITDA is between $74.6 million and $78.5 million and/or ROIC is between 11.6% and 12.2%. As part of the grant, recipient has also received a performance right that entitles the recipient to receive additional shares of common stock (ranging from 0-50% of the amount of shares of restricted stock currently being granted) if 2018 fiscal year Adjusted EBITDA is between $78.5 million and $86.4 million and/or 2018 fiscal year ROIC is between 12.2% and 13.5%.
These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2015.
/s/ Jeffrey M. Schumm, by power of attorney
2015-07-01